Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Flyer for the industry insight seminar featuring Visusnano on 4 May 2021 at 12 noon.

May's edition of the IISS features Joanna Gould - CEO, VisusNano.

Talk title: Improving drug delivery in ophthalmology

VisusNano Ltd. is a pre-clinical company developing a pipeline of exciting drug-eluting intraocular lens implant for use in patients undergoing cataract surgery. By improving patient outcomes, obviating the need for eye drops after surgery, and avoiding the need for laser treatment after surgery, our project has the potential to revolutionise cataract surgery in both the human and veterinary markets.

To register for this event, click here.

For more information on VisusNano, click here.